You are here:Home-Chemical Inhibitors & Agonists-Ras-Raf-MAPK-ERK Pathway-MEK (MAP2K)-Binimetinib
Binimetinib

Chemical Structure : Binimetinib

CAS No.: 606143-89-9

Binimetinib (MEK162, ARRY-162, ARRY-438162)

Catalog No.: PC-49771Not For Human Use, Lab Use Only.

Binimetinib (ARRY-162, ARRY-438162, MEK162) is a potent, selective and non-competitive inhibitor of MEK1/2 with IC50 of 12 nM in cell-free assays.

Packing Price Stock Quantity
250 mg $158 In stock
1 g $358 In stock
5 g Get quote
10 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Binimetinib (ARRY-162, ARRY-438162, MEK162) is a potent, selective and non-competitive inhibitor of MEK1/2 with IC50 of 12 nM in cell-free assays.
Binimetinib (ARRY-162, ARRY-438162, MEK162) induces G1 cell cycle arrest and apoptosis in human NSCLC cell lines and induces autophagy.
Binimetinib (ARRY-162, ARRY-438162, MEK162) inhibits in vitro osteoclast differentiation with IC50 of 39 nM.
Binimetinib (ARRY-162, ARRY-438162, MEK162) (10 μM) inhibits in vitro osteoclast resorption with IC50 of 625 nM.
Binimetinib (ARRY-162, ARRY-438162, MEK162) inhibits pERK in cells with an IC50 of 11 nM.
Binimetinib (ARRY-162, ARRY-438162, MEK162) (1 μM) combined with MK-2206 (2 μM) completely reverses the resistance of RSK-expressing MCF7 cells.
Binimetinib (ARRY-162, ARRY-438162, MEK162) (10 mg/kg, po, bid) reduces disease severity in a dose-related manner in rat collagen-induced arthritis (CIA) and rat adjuvant-induced arthritis (AIA) models.
Binimetinib (ARRY-162, ARRY-438162, MEK162) (6 mg/kg, BID) combined with BEZ235 treatment caused a significant reduction of tumor growth in immunodeficient mice injected with MCF7 cells.

Physicochemical Properties

M.Wt 441.23
Formula C17H15BrF2N4O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

5-((4-Bromo-2-fluorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide

References

1. Ascierto PA, et al. Lancet Oncol. 2013 Mar;14(3):249-56.

2. Gritsman K, et al. J Clin Invest. 2014 Apr;124(4):1794-809.

3. Johanna C Bendell, et al. Br J Cancer. 2017 Feb 28;116(5):575-583.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: